Shares of Intuitive Surgical, Inc. (NASDAQ:ISRG – Get Free Report) have been assigned a consensus recommendation of “Moderate Buy” from the eighteen research firms that are covering the stock, Marketbeat reports. One equities research analyst has rated the stock with a sell recommendation, two have issued a hold recommendation and fifteen have given a buy recommendation to the company. The average 12 month price objective among brokers that have covered the stock in the last year is $583.83.
Several analysts recently weighed in on the stock. BTIG Research lifted their price objective on shares of Intuitive Surgical from $535.00 to $561.00 and gave the company a “buy” rating in a research report on Tuesday, November 26th. Stifel Nicolaus raised their target price on Intuitive Surgical from $525.00 to $610.00 and gave the company a “buy” rating in a research report on Thursday, December 5th. Robert W. Baird boosted their price target on Intuitive Surgical from $503.00 to $565.00 and gave the stock an “outperform” rating in a research report on Thursday, October 17th. Raymond James lifted their price objective on shares of Intuitive Surgical from $560.00 to $688.00 and gave the company an “outperform” rating in a research note on Friday. Finally, Truist Financial raised their target price on shares of Intuitive Surgical from $640.00 to $666.00 and gave the company a “buy” rating in a research note on Friday.
View Our Latest Stock Analysis on Intuitive Surgical
Intuitive Surgical Price Performance
Insiders Place Their Bets
In related news, EVP Robert Desantis sold 376 shares of the business’s stock in a transaction that occurred on Friday, November 29th. The stock was sold at an average price of $539.00, for a total value of $202,664.00. Following the completion of the sale, the executive vice president now owns 5,506 shares of the company’s stock, valued at approximately $2,967,734. The trade was a 6.39 % decrease in their position. The sale was disclosed in a filing with the SEC, which can be accessed through this link. Also, CFO Jamie Samath sold 108 shares of the firm’s stock in a transaction that occurred on Tuesday, November 26th. The shares were sold at an average price of $542.06, for a total transaction of $58,542.48. Following the transaction, the chief financial officer now directly owns 8,757 shares in the company, valued at approximately $4,746,819.42. The trade was a 1.22 % decrease in their position. The disclosure for this sale can be found here. In the last ninety days, insiders sold 42,453 shares of company stock worth $22,059,506. 0.90% of the stock is currently owned by company insiders.
Institutional Inflows and Outflows
A number of hedge funds and other institutional investors have recently modified their holdings of ISRG. Berbice Capital Management LLC bought a new position in Intuitive Surgical during the fourth quarter valued at about $26,000. Godsey & Gibb Inc. lifted its holdings in Intuitive Surgical by 140.0% in the 3rd quarter. Godsey & Gibb Inc. now owns 60 shares of the medical equipment provider’s stock worth $29,000 after purchasing an additional 35 shares during the last quarter. MidAtlantic Capital Management Inc. bought a new stake in Intuitive Surgical during the third quarter worth approximately $33,000. Decker Retirement Planning Inc. acquired a new position in Intuitive Surgical during the fourth quarter valued at approximately $36,000. Finally, Capital Performance Advisors LLP bought a new position in shares of Intuitive Surgical in the third quarter valued at approximately $38,000. Institutional investors own 83.64% of the company’s stock.
Intuitive Surgical Company Profile
Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.
Featured Stories
- Five stocks we like better than Intuitive Surgical
- Biggest Stock Losers – Today’s Biggest Percentage Decliners
- MP Materials: Rare Earth Elements Powering the EV Boom
- 2 Fintech Stocks to Buy Now and 1 to Avoid
- Verizon’s Turnaround Gains Traction: New Highs Are Likely in 2025
- How to Evaluate a Stock Before Buying
- Bloom Energy: Powering the Future With Decentralized Energy
Receive News & Ratings for Intuitive Surgical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intuitive Surgical and related companies with MarketBeat.com's FREE daily email newsletter.